Dr. Falk Pharma AG is a company in digestive and metabolic medicine that develops and distributes pharmaceuticals for gastroenterology and hepatology. Its activities include marketing prescription medicines (e.g. Salofalk, Budenofalk, Ursofalk, Jorveza, Azafalk), supporting medical projects, and providing educational and patient information resources.
AI-generated
Offering
Products & services
Industry:Research & DevelopmentPharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Prescription medicines for gastroenterology and hepatology, including Budenofalk®, Jorveza®, Salofalk® and Ursofalk® in various dosage forms.
Information on indications
Information on ulcerative colitis, eosinophilic oesophagitis, haemorrhoidal disease, microscopic colitis, Crohn's disease and primary biliary cholangitis.
Patient and professional information
Patient guides, brochures, in-depth information for medical professionals, Falk Gastro Education, Falk Gastro Review Journal and symposium contents.
Patient organisations
Addresses and information on patient organisations and self-help groups for diseases of the oesophagus, the intestine and the liver.
Events
Events, continuing education sessions, symposia and webinars with CME credits, online or on site, on gastroenterology and hepatology topics.
Medical projects
Disputatio Controversia and Innovation Award to promote research, new therapeutic approaches and scientific exchange in gastroenterology and hepatology.
Comparisons
Dr. Falk Pharma AG in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Dr. Falk Pharma AG by reviews, experience and specialisations.
Knowledge
No knowledge articles yet
Once Dr. Falk Pharma AG has claimed this profile, we'll publish editorial articles and case studies here together.